HomeInsights52 Week High Stocks

Shilpa Medicare Ltd 52 Week High

Shilpa Medicare Ltd 52 Week High

stocks purchased

₹ 2.6 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

28.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

YEARHIGH

₹ 959.95

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Shilpa Medicare Ltd is ₹ 959.95 as of 22 Nov 24 .

Company Fundamentals for Shilpa Medicare Ltd

No data available

Market Price of Shilpa Medicare Ltd

1M

1Y

3Y

5Y

Monitoring Shilpa Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024911
21 Nov 2024935.8
19 Nov 2024879.9
18 Nov 2024863.4
14 Nov 2024872.9
13 Nov 2024824.75
12 Nov 2024878.05
11 Nov 2024893.2
08 Nov 2024852.7
07 Nov 2024843.4

Asset Value vs Market Value of Shilpa Medicare Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Shilpa Medicare Ltd

No data available

* All values are in crore

Shilpa Medicare Ltd News Hub

News

Shilpa Medicare spurts on European regulator nod for Octreotide & Nifedipine

Octreotide, a synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid-p...

Read more

19 Nov 202411:24

News

Shilpa Medicare rallies after robust Q2 results

Profit before tax (PBT) surged 300.98% to Rs 36.77 crore in Q2 FY25 over Q2 FY24. EBITDA j...

Read more

14 Nov 202410:39

News

Shilpa Medicare update on its CDMO partner - Unicycive Therapeutics

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) has announced that the U.S. Food and Drug Admi...

Read more

12 Nov 202415:02

News

Shilpa Medicare schedules board meeting

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 13 Novembe...

Read more

04 Nov 202418:42

News

Shilpa Medicare slips after US FDA issues four form 483 obersvations to Bengaluru facility

In a regulatory filing made during market hours today, the company informed the company's ...

Read more

31 Oct 202413:43

News

Shilpa Medicare arm gets CEP from EDQM for Desmopressin

Desmopressin is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid...

Read more

04 Oct 202408:40

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Shilpa Medicare Ltd

What is the significance of Shilpa Medicare Ltd reaching its 52-week high?

Shilpa Medicare Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Shilpa Medicare Ltd 52-week high?

Investors monitor Shilpa Medicare Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Shilpa Medicare Ltd a good buy when it hits its 52-week high?

Whether Shilpa Medicare Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Shilpa Medicare Ltd fundamentals.

What should I consider before investing in Shilpa Medicare Ltd at its 52-week high?

Before investing in Shilpa Medicare Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Shilpa Medicare Ltd stock price continue to rise after reaching its 52-week high?

Shilpa Medicare Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*